Diabetes is a chronic condition caused by the body’s inability to produce or make use of insulin
Haemophilia is an inherited (congenital) bleeding disorder that affects males.
Growth Hormone is crucial to the healthy development and functioning of the human body
HRT is used to treat climacteric symptoms of women in different stages of the menopause
Novo Nordisk Pro is the official Novo Nordisk online resource exclusively for healthcare professionals
Board of Directors and Executive Management
How we are managed, directed and controlled
Download reports, magazines and presentations
Novo Nordisk Annual Report 2013
accounts for our financial, social and
environmental performance in one
Annual reporting requirement by the US Securities and Exchange Commission (SEC) for foreign private issuers with equity shares listed on exchanges in the United States. Form 20-F is filed using a standardised reporting form so that investors can evaluate the company alongside US domestic equities.
Requirement according to the Danish Financial Statements Act. Reporting of compliance with Danish Corporate Governance Recommendations.
Voluntary Communication on Progress reporting in the form of the United Nations and its 10 principles in the areas of human rights, labour rights, environment and anti-corruption. As a LEAD member, Novo Nordisk provides additional progress reporting on corporate sustainability leadership and UN goals.
This reporting also fulfils the requirements of the Danish Financial Statements Act, sections 99a and 99b, on policies and actions for corporate responsibility and progress against targets for diversity in management.
Order the Annual Report 2014 in English or Novo Nordisk Årsskrift 2014 in Danish via our printer’s website.
Please note that printed versions are not available until after 20 February 2015.
Please tell us what you think about our Annual Report.
Does it meet your information needs?
Is it comprehensible?
You can help improve our reporting by answering six short questions: English | Danish
Reporting of target figures and diversity policy for the under-represented gender according to the Danish Financial Statements Act.